Literature DB >> 22106945

Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity.

Darren G N Craig1, Caroline M Bates, Janice S Davidson, Kirsty G Martin, Peter C Hayes, Kenneth J Simpson.   

Abstract

AIMS: Paracetamol (acetaminophen) poisoning remains the major cause of severe acute hepatotoxicity in the UK. In this large single centre cohort study we examined the clinical impact of staggered overdoses and delayed presentation following paracetamol overdose.
RESULTS: Between 1992 and 2008, 663 patients were admitted with paracetamol-induced severe liver injury, of whom 161 (24.3%) had taken a staggered overdose. Staggered overdose patients were significantly older and more likely to abuse alcohol than single time point overdose patients. Relief of pain (58.2%) was the commonest rationale for repeated supratherapeutic ingestion. Despite lower total ingested paracetamol doses and lower admission serum alanine aminotransferase concentrations, staggered overdose patients were more likely to be encephalopathic on admission, require renal replacement therapy or mechanical ventilation and had higher mortality rates compared with single time point overdoses (37.3% vs. 27.8%, P= 0.025), although this overdose pattern did not independently predict death. The King's College poor prognostic criteria had reduced sensitivity (77.6, 95% CI 70.8, 81.5) for this pattern of overdose. Of the 396/450 (88.0%) single time point overdoses in whom accurate timings could be obtained, 178 (44.9%) presented to medical services >24 h following overdose. Delayed presentation beyond 24 h post overdose was independently associated with death/liver transplantation (OR 2.25, 95% CI 1.23, 4.12, P= 0.009).
CONCLUSIONS: Both delayed presentation and staggered overdose pattern are associated with adverse outcomes following paracetamol overdose. These patients are at increased risk of developing multi-organ failure and should be considered for early transfer to specialist liver centres.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22106945      PMCID: PMC3269587          DOI: 10.1111/j.1365-2125.2011.04067.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Acetaminophen toxicity in an urban county hospital.

Authors:  F V Schiødt; F A Rochling; D L Casey; W M Lee
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

2.  Acetaminophen toxicity in an urban county hospital.

Authors:  A M Walker
Journal:  N Engl J Med       Date:  1998-02-19       Impact factor: 91.245

3.  Age and paracetamol self-poisoning.

Authors:  L E Schmidt
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993).

Authors:  A J Makin; J Wendon; R Williams
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

5.  Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.

Authors:  Anne M Larson; Julie Polson; Robert J Fontana; Timothy J Davern; Ezmina Lalani; Linda S Hynan; Joan S Reisch; Frank V Schiødt; George Ostapowicz; A Obaid Shakil; William M Lee
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

6.  Prediction of hepatic encephalopathy in paracetamol overdose: a prospective and validated study.

Authors:  F V Schiødt; S Bondesen; N Tygstrup; E Christensen
Journal:  Scand J Gastroenterol       Date:  1999-07       Impact factor: 2.423

7.  Use and outcome of liver transplantation in acetaminophen-induced acute liver failure.

Authors:  W Bernal; J Wendon; M Rela; N Heaton; R Williams
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

8.  Association of acetaminophen hepatotoxicity with fasting and ethanol use.

Authors:  D C Whitcomb; G D Block
Journal:  JAMA       Date:  1994-12-21       Impact factor: 56.272

9.  Does the patient history predict hepatotoxicity after acute paracetamol overdose?

Authors:  W S Waring; O D G Robinson; A F L Stephen; M A Dow; J M Pettie
Journal:  QJM       Date:  2008-01-07

10.  Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.

Authors:  L F Prescott; R N Illingworth; J A Critchley; M J Stewart; R D Adam; A T Proudfoot
Journal:  Br Med J       Date:  1979-11-03
View more
  44 in total

1.  Liver: determining prognosis in acute liver failure.

Authors:  William M Lee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-06       Impact factor: 46.802

Review 2.  Managing osteoarthritis.

Authors:  Shirley P Yu; David J Hunter
Journal:  Aust Prescr       Date:  2015-08-03

3.  Authors' response to Dr Reiter.

Authors:  Darren G Craig; Peter C Hayes; Kenneth J Simpson
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

4.  The toxicity of paracetamol-codeine combination in overdose is an unresolved issue.

Authors:  Christopher N Floyd; Paul I Dargan
Journal:  Br J Clin Pharmacol       Date:  2017-07-30       Impact factor: 4.335

Review 5.  Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away?

Authors:  William M Lee
Journal:  J Hepatol       Date:  2017-07-20       Impact factor: 25.083

6.  Osteoarthritis: Is viscosupplementation really so unsafe for knee OA?

Authors:  Timothy E McAlindon; Raveendhara R Bannuru
Journal:  Nat Rev Rheumatol       Date:  2012-09-11       Impact factor: 20.543

Review 7.  Type 2 diabetes mellitus and osteoarthritis.

Authors:  Nicola Veronese; Cyrus Cooper; Jean-Yves Reginster; Marc Hochberg; Jaime Branco; Olivier Bruyère; Roland Chapurlat; Nasser Al-Daghri; Elaine Dennison; Gabriel Herrero-Beaumont; Jean-François Kaux; Emmanuel Maheu; René Rizzoli; Roland Roth; Lucio C Rovati; Daniel Uebelhart; Mila Vlaskovska; André Scheen
Journal:  Semin Arthritis Rheum       Date:  2019-01-11       Impact factor: 5.532

8.  Osteoarthritis: Yet another death knell for paracetamol in OA.

Authors:  David J Hunter; Manuela L Ferreira
Journal:  Nat Rev Rheumatol       Date:  2016-05-24       Impact factor: 20.543

9.  Psychosocial and behavioral factors in acetaminophen-related acute liver failure and liver injury.

Authors:  Carla Pezzia; Corron Sanders; Suzanne Welch; Angela Bowling; William M Lee
Journal:  J Psychosom Res       Date:  2017-08-04       Impact factor: 3.006

10.  Acetaminophen hepatotoxicity in mice: Effect of age, frailty and exposure type.

Authors:  Alice E Kane; Sarah J Mitchell; John Mach; Aniko Huizer-Pajkos; Catriona McKenzie; Brett Jones; Victoria Cogger; David G Le Couteur; Rafael de Cabo; Sarah N Hilmer
Journal:  Exp Gerontol       Date:  2015-11-23       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.